Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Viz.ai

< Previous 1 2 Next >
News headline image
Viz.ai to Participate in Morgan Stanley 22nd Annual Healthcare Conference
From Viz.ai
Via Business Wire
News headline image
Viz.ai Strengthens Information Security with ISO-27001:2022 Certification
From Viz.ai
Via Business Wire
News headline image
Viz.ai Wins Comparably Awards for Best Place to Work for Third Consecutive Year
From Viz.ai
Via Business Wire
News headline image
Viz.ai and UTMB Announce Collaboration to Accelerate Recruitment in the CHESS Study with Viz Subdural Solution
From Viz.ai
Via Business Wire
News headline image
Viz.ai Wins 2024 Edison Award™ for Innovation for Second Year in a Row
From Viz.ai
Via Business Wire
News headline image
Viz.ai and NICO Corporation Announce Collaboration to Improve Outcomes in Patients with Intracerebral Hemorrhage
From Viz.ai
Via Business Wire
News headline image
Viz.ai® Announces Three New Studies Supporting Viz HCM™ Module for the Detection and Management of Suspected Hypertrophic Cardiomyopathy
From Viz.ai
Via Business Wire
News headline image
Viz.ai Names Michael Herring as Chief Financial Officer
From Viz.ai
Via Business Wire
News headline image
Viz.ai Named One of the World’s Most Innovative Companies by Fast Company Magazine
From Viz.ai
Via Business Wire
News headline image
Viz.ai Broadens Healthcare System Integrations to Inform Critical Decisions at the Point of Care
From Viz.ai
Via Business Wire
News headline image
New Viz.ai Study Demonstrates Reduced Mortality Rates in Patients with Pulmonary Embolism
From Viz.ai
Via Business Wire
News headline image
Viz.ai Announces Successful Completion of SOC 2 Type II + HIPAA Audits for Viz.ai One Platform
From Viz.ai
Via Business Wire
News headline image
Viz.ai Receives FDA 510(k) Clearance for Artificial Intelligence Algorithm for the Quantification of Intracerebral Hemorrhage
From Viz.ai
Via Business Wire
News headline image
CORRECTING and REPLACING Viz.ai Announces Six Clinical Studies that Further Validate Impact of Viz™ Neuro Suite on Patient Care
From Viz.ai
Via Business Wire
News headline image
Viz.ai Adoption Surpasses 1,500 Hospitals Nationwide
From Viz.ai
Via Business Wire
News headline image
Viz.ai Honored by Goldman Sachs for Entrepreneurship
From Viz.ai
Via Business Wire
News headline image
Viz.ai Signs License Agreement with UCSF to Commercialize Three Cardiac Artificial Intelligence Algorithms
From Viz.ai
Via Business Wire
News headline image
Viz.ai Receives First De Novo Approval by the FDA for Hypertrophic Cardiomyopathy AI Algorithm
From Viz.ai
Via Business Wire
News headline image
Three New Clinical Studies Presented at the Society of Neurointerventional Surgery Annual Meeting Further Validate Impact of Viz™ Neuro Suite
From Viz.ai
Via Business Wire
News headline image
Viz.ai Joins the World Economic Forum as a Unicorn in the Innovator Communities
From Viz.ai
Via Business Wire
News headline image
Viz.ai Appoints Hypertrophic Cardiomyopathy Medical Advisory Board to Advance Innovation
From Viz.ai
Via Business Wire
News headline image
Viz.ai Wins 2023 Gold Edison Award™ for Innovation
From Viz.ai
Via Business Wire
News headline image
Viz.ai Named One of Fierce Medtech’s “Fierce 15” Companies of 2022
From Viz.ai
Via Business Wire
News headline image
Viz.ai Launches AI-Powered Viz™ Vascular Suite
From Viz.ai
Via Business Wire
News headline image
Viz.ai Wins Four Comparably Awards for Best Place to Work
From Viz.ai
Via Business Wire
News headline image
Viz.ai Launches AI-powered Viz™ Radiology Suite
From Viz.ai
Via Business Wire
News headline image
Viz.ai™ Announces Positive New Data From Large Aortic Dissection AI Real-World Study at the 2022 VEITHsymposium™
From Viz.ai
Via Business Wire
News headline image
INSERTING and REPLACING Viz.ai Receives FDA 510(k) Clearance for Viz SDH
From Viz.ai
Via Business Wire
News headline image
Viz.ai Raises $100 Million in Series D Funding, Led by Tiger Global and Insight Partners at $1.2 Billion Valuation
From Viz.ai
Via Business Wire
News headline image
Viz.ai and Avicenna.AI Partner to Launch World-class AI-Driven Intelligent Care Coordination for Pulmonary Embolism and Aortic Disease
From Viz.ai
Via Business Wire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.